Yunkang Group Limited (HK:2325) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Yunkang Group Limited has successfully passed a resolution at its extraordinary general meeting, approving a new procurement agreement with Daan Gene Co., Ltd. for the purchase of reagents, consumables, and equipment from 2025 to 2027. With 100% of eligible votes cast in favor, the agreement sets annual caps of up to RMB64.193 million by 2027, marking a significant step for the company in securing essential supplies for future operations.
For further insights into HK:2325 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- ‘Keep On Buying,’ Says Investor About Microsoft Stock
- ‘Priced for Fantasy,’ Says Investor About Tesla Stock
- ‘Remain Skeptical,’ Says Top Investor About AMD Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
